Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 10,223 shares at $566.37 ($5.8M) on 2020-05-07, disclosed to the SEC on 2020-05-08.
Open-market sale of $5.8M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $565.64 | 1,722 | $974K | 16.8% |
| 2 | $565.64 | 1,722 | $974K | 16.8% |
| 3 | $566.37 | 2,128 | $1.2M | 20.8% |
| 4 | $566.37 | 2,128 | $1.2M | 20.8% |
| 5 | $567.58 | 646 | $367K | 6.3% |
| 6 | $567.58 | 646 |
| $367K |
| 6.3% |
| 7 | $568.37 | 609 | $346K | 6.0% |
| 8 | $568.37 | 609 | $346K | 6.0% |
| 9 | $569.20 | 13 | $7K | 0.1% |
| Total | $566.52 avg | 10,223 | $5.8M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $1.0M | — | Filing → |
| REGN | SELL | 2023-10-17 | $850K | — | Filing → |
| REGN | SELL | 2022-03-18 | $1.4M | — | Filing → |